Skip to main content

GLP-1 Medical Weight Loss Success Stories & Expectations: Webinars Announced

ⓘ This article is third-party content and does not represent the views of this site. We make no guarantees regarding its accuracy or completeness.

OrderlyMeds has announced webinars for patients who have enrolled in the company’s GLP-1 weight loss programs.

-- OrderlyMeds recently announced it will be hosting webinars for patients currently undergoing GLP-1 therapy as part of the company’s medical weight loss programs. Covering initial orientation and GLP-1 success stories, both events will be held on separate dates in June and July.

For more information, please visit https://orderlymeds.com/resources/resource-webinar/expert-support-events/

The first of OrderlyMeds’ webinars will focus on what patients can expect within the first 90 days of beginning GLP-1 medications. Dr. Brian Spears, board-certified general surgeon and Chief Medical Officer at OrderlyMeds, will host this 60-minute webinar, going over topics such as how GLP-1 medications work on the body, normal and abnormal side effects individuals may see during the initial three-month period, and how to manage these side effects. He will also highlight the importance of nutrition, as well as specific lifestyle adjustments that can help patients get the most out of their treatment.

Various resources available to customers will also be covered during the event, ensuring patients are aware of tools that can help with meal plans, exercise, mental health, and more.

The second webinar is part of a new series being offered by OrderlyMeds, and it will focus on the experiences of customers who have successfully lost weight through GLP-1 therapy. These webinars will feature guided conversations led by clinical psychologist Dr. Katie Rickel, who will invite two guests to share their motivation, the surprises and setbacks they encountered during their treatment, and helpful strategies they employed to maintain their progress. The final 10 to 15 minutes of the event will be reserved for a live Q&A session, where attendees can ask both Dr. Rickel and her guests questions via chat.

Although live attendance is encouraged, it is not required, as the webinars will be recorded and added to OrderlyMeds’ list of patient resources once the events are over. The exact date of the sessions will be announced on the company’s website.

About OrderlyMeds

OrderlyMeds is a fully online weight loss platform developed to make medical weight loss accessible to the public. The company believes in personalized, holistic support that combines evidence-based medications with a healthy lifestyle for sustained progress over the long term.

More information is available at https://orderlymeds.com/

Contact Info:
Name: Annie Dawson
Email: Send Email
Organization: OrderlyMeds
Address: 235 Ponce De Leon Pl Suite M347, Decatur, Georgia 30030, United States
Website: https://orderlymeds.com/

Source: PressCable

Release ID: 89195946

If there are any deficiencies, problems, or concerns regarding the information presented in this press release that require attention or if you need assistance with a press release takedown, we encourage you to notify us without delay at error@releasecontact.com (it is important to note that this email is the authorized channel for such matters, sending multiple emails to multiple addresses does not necessarily help expedite your request). Our diligent team is committed to promptly addressing your concerns within 8 hours and taking necessary actions to rectify any identified issues or facilitate the removal process. Providing accurate and trustworthy information is of utmost importance.

Report this content

If you believe this article contains misleading, harmful, or spam content, please let us know.

Report this article

Recent Quotes

View More
Symbol Price Change (%)
AMZN  227.01
-7.26 (-3.10%)
AAPL  275.15
-17.93 (-6.12%)
AMD  532.57
+12.83 (2.47%)
BAC  58.19
+0.46 (0.80%)
GOOG  342.19
-2.85 (-0.83%)
META  542.87
-14.80 (-2.65%)
MSFT  352.83
-12.63 (-3.46%)
NVDA  195.74
-3.26 (-1.64%)
ORCL  152.46
-5.07 (-3.22%)
TSLA  375.12
-0.41 (-0.11%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.